- Home
- EFR vs RLMD Comparison
EFR vs RLMD Comparison
Compare EFR & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFR | RLMD |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.9M | 319.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EFR | RLMD |
|---|---|---|
| Price | $11.24 | $3.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 88.6K | ★ 725.3K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 9.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.95 | $0.24 |
| 52 Week High | $13.29 | $5.12 |
Technical Indicators
Market Signals| Indicator | EFR | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.56 | 41.05 |
| Support Level | $11.01 | $3.98 |
| Resistance Level | $11.36 | $4.49 |
| Average True Range (ATR) | 0.07 | 0.34 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 65.03 | 3.23 |
Price Performance
Historical ComparisonAbout EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.